UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 33

Sortiert nach

Aberrant MNX1 expression associated with t(7;12)(q36;p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation

Haematologica (Roma), 2024-03, Vol.109 (3), p.725

2024

Volltextzugriff (PDF)

The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia

PloS one, 2016-09, Vol.11 (9), p.e0162638-e0162638

2016

Volltextzugriff (PDF)

α7 Nicotinic acetylcholine receptor is expressed in human atherosclerosis and inhibits disease in mice--brief report

Arteriosclerosis, thrombosis, and vascular biology, 2014-12, Vol.34 (12), p.2632

2014

Volltextzugriff (PDF)

Patient‐tailored analysis of minimal residual disease in acute myeloid leukemia using next‐generation sequencing

European journal of haematology, 2017-01, Vol.98 (1), p.26-37

2017

Volltextzugriff (PDF)

A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

Frontiers in medicine, 2022, Vol.9, p.842507-842507

2022

Volltextzugriff (PDF)

Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia

Haematologica (Roma), 2018-02, Vol.103 (2), p.246

2018

Volltextzugriff (PDF)

PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia

Haematologica (Roma), 2016-01, Vol.101 (1), p.e20

2016

Volltextzugriff (PDF)

Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group

Biomedicines, 2022-06, Vol.10 (7), p.1530

2022

Volltextzugriff (PDF)

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Leukemia, 2022-07, Vol.36 (7), p.1703-1719

2022

Volltextzugriff (PDF)

Infection with Neoehrlichia mikurensis promotes the development of malignant B‐cell lymphomas

British journal of haematology, 2023-05, Vol.201 (3), p.480-488

2023

Volltextzugriff (PDF)

Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO‐AML 2004 study

British journal of haematology, 2016-08, Vol.174 (4), p.600-609

2016

Volltextzugriff (PDF)

Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice

Oncogene, 2017-03, Vol.36 (11), p.1516-1524

2017

Volltextzugriff (PDF)

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial

Journal of internal medicine, 2022-12, Vol.292 (6), p.925-940

2022

Volltextzugriff (PDF)

Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia

British journal of haematology, 2020-07, Vol.190 (2), p.198-208

2020

Volltextzugriff (PDF)

Early hematopoiesis in multiple sclerosis patients

Journal of neuroimmunology, 2016-10, Vol.299, p.158-163

2016

Volltextzugriff (PDF)

MicroRNA-155 is upregulated in MLL rearranged AML but its absence does not affect leukemia development

Experimental hematology, 2016-12, Vol.44 (12), p.1166-1171

2016

Volltextzugriff (PDF)

Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6–RUNX1: concordant results using quantitation of fusion transcript and flow cytometry

International journal of laboratory hematology, 2017-04, Vol.39 (2), p.121-128

2017

Volltextzugriff (PDF)

Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

Leukemia & lymphoma, 2019-01, Vol.60 (2), p.409-417

2019

Volltextzugriff (PDF)

Exploring the heterogeneity of the hematopoietic stem and progenitor cell pool in cord blood: simultaneous staining for side population, aldehyde dehydrogenase activity, and CD34 expression

Transfusion (Philadelphia, Pa.), 2015-06, Vol.55 (6), p.1283-1289

2015

Volltextzugriff (PDF)

Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study

Leukemia & lymphoma, 2021, Vol.62 (8), p.1973-1981

2021

Volltextzugriff (PDF)

Rip2 Deficiency Leads to Increased Atherosclerosis Despite Decreased Inflammation

Circulation research, 2011-11, Vol.109 (11), p.1210-1218

2011

Volltextzugriff (PDF)

CD99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia

British journal of haematology, 2019-02, Vol.184 (3), p.418-423

2019

Volltextzugriff (PDF)

The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia

Leukemia research, 2018-12, Vol.75, p.61-68

2018

Volltextzugriff (PDF)

1 – 25 von 33

Suche als RSS-Feed

Aktive Filter

ThemaHematology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(33)
Mit Volltextzugriff
(27)

Publikationsform

Artikel
(33)

Sprache

Englisch
(33)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Aberrant MNX1 expression associated with t(7;12)(q36;p13) pediatric acute myeloid leukemia induces the disease through altering histone methylation

The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia

MicroRNA-708 is a novel regulator of the Hoxa9 program in myeloid cells

α7 Nicotinic acetylcholine receptor is expressed in human atherosclerosis and inhibits disease in mice--brief report

Patient‐tailored analysis of minimal residual disease in acute myeloid leukemia using next‐generation sequencing

A Study Protocol for Validation and Implementation of Whole-Genome and -Transcriptome Sequencing as a Comprehensive Precision Diagnostic Test in Acute Leukemias

Micro-ribonucleic acid-155 is a direct target of Meis1, but not a driver in acute myeloid leukemia

PAX5-ESRRB is a recurrent fusion gene in B-cell precursor pediatric acute lymphoblastic leukemia

Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group

Duplex Sequencing Uncovers Recurrent Low‐frequency Cancer‐associated Mutations in Infant and Childhood KMT2A‐rearranged Acute Leukemia

The 5th edition of the World Health Organization Classification of Haematolymphoid Tumours: Myeloid and Histiocytic/Dendritic Neoplasms

Infection with Neoehrlichia mikurensis promotes the development of malignant B‐cell lymphomas

Residual disease detected by flow cytometry is an independent predictor of survival in childhood acute myeloid leukaemia; results of the NOPHO‐AML 2004 study

Upregulation of Flt3 is a passive event in Hoxa9/Meis1-induced acute myeloid leukemia in mice

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial

Measurable residual disease assessment by qPCR in peripheral blood is an informative tool for disease surveillance in childhood acute myeloid leukaemia

Early hematopoiesis in multiple sclerosis patients

MicroRNA-155 is upregulated in MLL rearranged AML but its absence does not affect leukemia development

Minimal residual disease monitoring in childhood B lymphoblastic leukemia with t(12;21)(p13;q22); ETV6–RUNX1: concordant results using quantitation of fusion transcript and flow cytometry

Minimal residual disease assessed with deep sequencing of NPM1 mutations predicts relapse after allogeneic stem cell transplant in AML

Exploring the heterogeneity of the hematopoietic stem and progenitor cell pool in cord blood: simultaneous staining for side population, aldehyde dehydrogenase activity, and CD34 expression

Is there an impact of measurable residual disease as assessed by multiparameter flow cytometry on survival of AML patients treated in clinical practice? A population-based study

Rip2 Deficiency Leads to Increased Atherosclerosis Despite Decreased Inflammation

CD99 expression is strongly associated with clinical outcome in children with B‐cell precursor acute lymphoblastic leukaemia

The endothelin receptor type A is a downstream target of Hoxa9 and Meis1 in acute myeloid leukemia

Aktive Filter

Suchergebnisse filtern